abstract |
The efficiency of dextran sulfate treatment is determined based on differences between the amount of biomarkers determined in a second biological sample taken from the patient following dextran sulfate administration and in a first biological sample taken from the patient prior to dextran sulfate administration.The biomarkers are selected from 6 groups consisting of PFA4and VAV3 (group 1); TNFSF15, IL-17B, TSLP and CRH(group 2); FGF1 and KITLG (group 3);BDNF, NOG and HBEGF (group 4);AFP,ATP2A3, SLC29A1,SLC40A1 and TTR(group 5);and SLC1A4, SLC7A11, SLC16A7, LDLR and ATP8A1(group 6). |